热门资讯> 正文
Reviva Pharmaceuticals宣布拟议公开募股
2025-09-19 04:18
- Reviva Pharmaceuticals Holdings (NASDAQ:RVPH) on Thursday said it intends to offer shares of its common stock and warrants to purchase shares of common stock in a public offering.
- All of the securities to be sold in the offering are to be offered by Reviva.
- The company currently intends to use the net proceeds from the offering to fund research and development activities and for working capital and other general corporate purposes.
- RVPH -21.31% after hours to $0.33.
- Source: Press Release
More on Reviva Pharmaceuticals
- Reviva Pharmaceuticals holdings announces pricing of $10M public offering
- Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals
- Historical earnings data for Reviva Pharmaceuticals
- Financial information for Reviva Pharmaceuticals
推荐文章
美股机会日报 | 华尔街乐观押注：利率降幅将远超美联储预测！以太坊跳水重挫超5%，加密货币概念股BitMine盘前一度跌近10%
一图看懂 | 两只易方达ETF开启认购！入场门槛为1500港元
新股申购 | 博泰车联今起招股！一手入场费2065.23港元
华盛早报 | 重磅！国新办将举行发布会；巴菲特已清仓比亚迪，累计套利至少80亿港元
美股“新宠”骤变：“昔日冷门”硬盘与内存站上AI风口 老牌存储厂商业绩股价齐飞
美联储政策路径不确定性仍存 中期美债备受交易员青睐
港股周报丨降息周期重启！美联储如期降息25个基点；港股通年内净流入突破1万亿港元
特朗普的H-1B签证10万美元新规引发科技公司混乱
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
